Correction: ERK mediates interferon gamma-induced melanoma cell death

Mol Cancer. 2024 Feb 5;23(1):29. doi: 10.1186/s12943-024-01949-5.

Ameya Champhekar¹, Rachel Heymans², Justin Saco^{2

3}, Guillem Turon Font², Cynthia Gonzalez², Anne Gao², John Pham², June Lee², Ryan Maryoung², Egmidio Medina², Katie M Campbell², Daniel Karin^{2

3}, David Austin⁴, Robert Damioseaux^{3

4

5

6}, Antoni Ribas^{7

8

9

10}

¹ Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA. achamphekar@mednet.ucla.edu.
² Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
³ Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.
⁴ California NanoSystems Institute, University of California, Los Angeles, CA, 90095, USA.
⁵ Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
⁶ Department of Bioengineering, Samueli School of Engineering, University of California, Los Angeles, CA, 90095, USA.
⁷ Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA. aribas@mednet.ucla.edu.
⁸ Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA. aribas@mednet.ucla.edu.
⁹ Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA. aribas@mednet.ucla.edu.
¹⁰ Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA. aribas@mednet.ucla.edu.

No abstract available

Publication types